Logo image of PRA

PROASSURANCE CORP (PRA) Stock Fundamental Analysis

NYSE:PRA - US74267C1062 - Common Stock

24 USD
+0.06 (+0.25%)
Last: 8/22/2025, 8:04:00 PM
24 USD
0 (0%)
After Hours: 8/22/2025, 8:04:00 PM
Fundamental Rating

3

Taking everything into account, PRA scores 3 out of 10 in our fundamental rating. PRA was compared to 143 industry peers in the Insurance industry. PRA may be in some trouble as it scores bad on both profitability and health. PRA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

PRA had positive earnings in the past year.
In the past year PRA has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: PRA reported negative net income in multiple years.
In multiple years PRA reported negative operating cash flow during the last 5 years.
PRA Yearly Net Income VS EBIT VS OCF VS FCFPRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

PRA has a Return On Assets (0.89%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 3.82%, PRA is doing worse than 75.52% of the companies in the same industry.
PRA has a Return On Invested Capital of 1.04%. This is comparable to the rest of the industry: PRA outperforms 41.96% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PRA is below the industry average of 4.08%.
The 3 year average ROIC (0.50%) for PRA is below the current ROIC(1.04%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.89%
ROE 3.82%
ROIC 1.04%
ROA(3y)0.08%
ROA(5y)-0.24%
ROE(3y)0.29%
ROE(5y)-0.41%
ROIC(3y)0.5%
ROIC(5y)N/A
PRA Yearly ROA, ROE, ROICPRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

With a Profit Margin value of 4.39%, PRA is not doing good in the industry: 64.34% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of PRA has grown nicely.
PRA has a Operating Margin of 6.11%. This is in the lower half of the industry: PRA underperforms 70.63% of its industry peers.
PRA's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.11%
PM (TTM) 4.39%
GM N/A
OM growth 3Y13.27%
OM growth 5Y78.9%
PM growth 3Y-29.65%
PM growth 5Y116.12%
GM growth 3YN/A
GM growth 5YN/A
PRA Yearly Profit, Operating, Gross MarginsPRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PRA is destroying value.
PRA has more shares outstanding than it did 1 year ago.
The number of shares outstanding for PRA has been reduced compared to 5 years ago.
PRA has a worse debt/assets ratio than last year.
PRA Yearly Shares OutstandingPRA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
PRA Yearly Total Debt VS Total AssetsPRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

PRA has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
PRA has a Debt to Equity ratio (0.33) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.13
WACC7.79%
PRA Yearly LT Debt VS Equity VS FCFPRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
PRA Yearly Current Assets VS Current LiabilitesPRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

4

3. Growth

3.1 Past

PRA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 610.53%, which is quite impressive.
Measured over the past years, PRA shows a very strong growth in Earnings Per Share. The EPS has been growing by 119.92% on average per year.
Looking at the last year, PRA shows a decrease in Revenue. The Revenue has decreased by -2.62% in the last year.
The Revenue has been growing slightly by 2.27% on average over the past years.
EPS 1Y (TTM)610.53%
EPS 3Y-10.31%
EPS 5Y119.92%
EPS Q2Q%126.09%
Revenue 1Y (TTM)-2.62%
Revenue growth 3Y1.68%
Revenue growth 5Y2.27%
Sales Q2Q%-3.12%

3.2 Future

PRA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.52% yearly.
PRA is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.50% yearly.
EPS Next Y19.05%
EPS Next 2Y6.61%
EPS Next 3Y10.52%
EPS Next 5YN/A
Revenue Next Year-0.56%
Revenue Next 2Y-0.47%
Revenue Next 3Y-0.5%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PRA Yearly Revenue VS EstimatesPRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
PRA Yearly EPS VS EstimatesPRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.78, PRA is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of PRA indicates a slightly more expensive valuation: PRA is more expensive than 63.64% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.24. PRA is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 20.91, PRA is valued on the expensive side.
72.03% of the companies in the same industry are cheaper than PRA, based on the Price/Forward Earnings ratio.
PRA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 35.82.
Industry RankSector Rank
PE 17.78
Fwd PE 20.91
PRA Price Earnings VS Forward Price EarningsPRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PRA is valued a bit more expensive than 63.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.42
PRA Per share dataPRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.93
PEG (5Y)0.15
EPS Next 2Y6.61%
EPS Next 3Y10.52%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.55%, PRA has a reasonable but not impressive dividend return.
PRA's Dividend Yield is comparable with the industry average which is at 3.42.
Compared to the average S&P500 Dividend Yield of 2.32, PRA is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.55%

5.2 History

PRA has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
PRA Yearly Dividends per sharePRA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 0.5 1 1.5

5.3 Sustainability

DP0%
EPS Next 2Y6.61%
EPS Next 3Y10.52%
PRA Yearly Income VS Free CF VS DividendPRA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

PROASSURANCE CORP

NYSE:PRA (8/22/2025, 8:04:00 PM)

After market: 24 0 (0%)

24

+0.06 (+0.25%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners87.47%
Inst Owner Change8.65%
Ins Owners1.29%
Ins Owner Change7.37%
Market Cap1.23B
Analysts49.23
Price Target23.12 (-3.67%)
Short Float %8.15%
Short Ratio7.12
Dividend
Industry RankSector Rank
Dividend Yield 1.55%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)55.31%
Min EPS beat(2)-34.55%
Max EPS beat(2)145.17%
EPS beat(4)3
Avg EPS beat(4)89.79%
Min EPS beat(4)-34.55%
Max EPS beat(4)145.17%
EPS beat(8)5
Avg EPS beat(8)22.31%
EPS beat(12)6
Avg EPS beat(12)-10.39%
EPS beat(16)9
Avg EPS beat(16)20.44%
Revenue beat(2)0
Avg Revenue beat(2)-2.81%
Min Revenue beat(2)-4.09%
Max Revenue beat(2)-1.53%
Revenue beat(4)0
Avg Revenue beat(4)-2.8%
Min Revenue beat(4)-4.09%
Max Revenue beat(4)-1.53%
Revenue beat(8)1
Avg Revenue beat(8)-3.93%
Revenue beat(12)2
Avg Revenue beat(12)-1.67%
Revenue beat(16)4
Avg Revenue beat(16)-1.12%
PT rev (1m)0%
PT rev (3m)11.48%
EPS NQ rev (1m)-0.99%
EPS NQ rev (3m)13.53%
EPS NY rev (1m)36.84%
EPS NY rev (3m)26.99%
Revenue NQ rev (1m)0.85%
Revenue NQ rev (3m)-0.24%
Revenue NY rev (1m)1.63%
Revenue NY rev (3m)0.67%
Valuation
Industry RankSector Rank
PE 17.78
Fwd PE 20.91
P/S 1.11
P/FCF N/A
P/OCF N/A
P/B 0.97
P/tB 1.01
EV/EBITDA 19.42
EPS(TTM)1.35
EY5.63%
EPS(NY)1.15
Fwd EY4.78%
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)-0.5
OCFYN/A
SpS21.58
BVpS24.81
TBVpS23.7
PEG (NY)0.93
PEG (5Y)0.15
Profitability
Industry RankSector Rank
ROA 0.89%
ROE 3.82%
ROCE 1.24%
ROIC 1.04%
ROICexc 1.04%
ROICexgc 1.17%
OM 6.11%
PM (TTM) 4.39%
GM N/A
FCFM N/A
ROA(3y)0.08%
ROA(5y)-0.24%
ROE(3y)0.29%
ROE(5y)-0.41%
ROIC(3y)0.5%
ROIC(5y)N/A
ROICexc(3y)0.51%
ROICexc(5y)N/A
ROICexgc(3y)0.58%
ROICexgc(5y)N/A
ROCE(3y)0.6%
ROCE(5y)N/A
ROICexcg growth 3Y18.48%
ROICexcg growth 5Y73.91%
ROICexc growth 3Y18.73%
ROICexc growth 5Y76.59%
OM growth 3Y13.27%
OM growth 5Y78.9%
PM growth 3Y-29.65%
PM growth 5Y116.12%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Debt/EBITDA 5.08
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC7.79%
ROIC/WACC0.13
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)610.53%
EPS 3Y-10.31%
EPS 5Y119.92%
EPS Q2Q%126.09%
EPS Next Y19.05%
EPS Next 2Y6.61%
EPS Next 3Y10.52%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.62%
Revenue growth 3Y1.68%
Revenue growth 5Y2.27%
Sales Q2Q%-3.12%
Revenue Next Year-0.56%
Revenue Next 2Y-0.47%
Revenue Next 3Y-0.5%
Revenue Next 5YN/A
EBIT growth 1Y79.29%
EBIT growth 3Y15.18%
EBIT growth 5Y82.96%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y70.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.58%
OCF growth 3YN/A
OCF growth 5YN/A